Invention Grant
US09562001B2 Monoamine reuptake inhibitors 有权
单胺再摄取抑制剂

Monoamine reuptake inhibitors
Abstract:
The invention provides bupropion analog compounds capable of inhibiting the reuptake of one or more monoamines. The compounds may selectively bind to one or more monoamine transporters, including those for dopamine, norepinephrine, and serotonin. Such compounds may be used to treat conditions that are responsive to inhibition of the reuptake of monoamines, including addiction, depression, and obesity.
Public/Granted literature
Information query
Patent Agency Ranking
0/0